Reset filter
Palabras clave
Médecine vasculaire ×
Mostrar más Palabras clave
Tabla de contenido
  1. 1. Ensayo clínico
  2. 2. Documentación de rutina
  3. 3. Estudio de registro / cohorte
  4. 4. Seguro de calidad
  5. 5. Estándar de datos
  6. 6. Resultado reportado por el paciente
  7. 7. Especialidad médica
    1. 7.1. Anestesiología
    1. 7.2. Dermatología
    1. 7.3. ENT
    1. 7.4. Geriatría
    1. 7.5. Ginecología / Obstetricia
    1. 7.6. Medicina Interna
      1. Hematología
      1. Enfermedades infecciosas
      1. Cardiología / Angiología
      1. Neumología
      1. Gastroenterología
      1. Nefrología
      1. Endocrinología / Enfermedades metabólicas
      1. Reumatología
    1. 7.7. Neurología
    1. 7.8. Oftalmología
    1. 7.9. Cuidados paliativos
    1. 7.10. Patología / Forense
    1. 7.11. Pediatría
    1. 7.12. Psiquiatría / Psicosomática
    1. 7.13. Radiología
    1. 7.14. Cirugía
      1. Cirugía General / Visceral
      1. Neurocirugía
      1. Cirugía plástica
      1. Cirugía Torácica
      1. Traumatología / Ortopedia
      1. Cirugía vascular
    1. 7.15. Urología
    1. 7.16. Odontología / OMS
Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

79 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

CEC - Stroke/TIA study Chronic Coronary Heart Disease NCT00799903 - CEC - Stroke/TIA GSK study Chronic Coronary Heart Disease NCT00799903

- 11/1/18 - 1 formulario, 3 itemgroups, 26 items, 1 idioma
Itemgroups: CEC - MI, Stroke - CEC Section, CEC STATUS
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: CEC - Stroke/TIA Repeating form (Scheduled visits)

Endpoint Stroke/TIA GSK study Chronic Coronary Heart Disease NCT00799903

- 4/1/18 - 1 formulario, 3 itemgroups, 55 items, 1 idioma
Itemgroups: Investigator Section, CEC Section, CEC STATUS
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Endpoint Stroke/TIA - Repeating form (Scheduled visits)

EHR Medical History Cardiac Patients - Anamnese Kardiologische Patienten

- 27/9/21 - 1 formulario, 2 itemgroups, 68 items, 2 idiomas
Itemgroups: Medical History, Indication and clinical question
EHR Medical History Cardiac Patients. From the University Hospital of Münster, Germany, Department of Nuclear Medicine. AN MS MSZ Studie NUK

Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; Clinical Study ID: AR1104574 - Stroke Report

- 13/8/18 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Administrative Data, Cerebrovascular event
Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism

Eligibility Heart Failure NCT01589601

- 12/1/20 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Palliative Care in Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01589601

Eligibility Atrial Fibrillation NCT01150214

- 30/7/19 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT01150214

Eligibility Syncope NCT01965899

- 28/9/21 - 1 formulario, 2 itemgroups, 15 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System; ODM derived from: https://clinicaltrials.gov/show/NCT01965899

Eligibility Healthy NCT02012725

- 2/4/19 - 1 formulario, 4 itemgroups, 18 items, 1 idioma
Itemgroups: Criteria, Inclusion Criteria, Exclusion Criteria, Inclusion Criteria
Molecular MRI of the Fibrotic Heart; ODM derived from: https://clinicaltrials.gov/show/NCT02012725

Eligibility Cardiovascular Disease NCT00631904

- 28/1/17 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
St. Mary's Duluth Clinic (SMDC) Pacemaker Magnetic Resonance Imaging (MRI) Study; ODM derived from: https://clinicaltrials.gov/show/NCT00631904

Eligibility Coronary Artery Disease NCT02233634

- 8/3/19 - 1 formulario, 2 itemgroups, 19 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Impact of Breathing Maneuvers on the Oxygenation Supply of the Heart Assessed With MRI in Patients With Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02233634

Eligibility Cardiovascular Disease NCT01178060

- 27/9/21 - 1 formulario, 2 itemgroups, 13 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Effectiveness of Personalized Stroke Risk Communication; ODM derived from: https://clinicaltrials.gov/show/NCT01178060

Eligibility Primary Hypertension NCT00794885

- 1/9/18 - 1 formulario, 2 itemgroups, 19 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
China Stroke Primary Prevention Trial; ODM derived from: https://clinicaltrials.gov/show/NCT00794885

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial